Cat Hair
Cat Hair is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Standardized Cat Hair. Available dosage form: injection.
Drug details
- Generic Name
- Cat Hair
- Brand Names
- Standardized Cat Hair
- Application Number
- BLA103473
- Sponsor
- Allermed Laboratories, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- CUTANEOUS, INTRADERMAL, SUBCUTANEOUS
- Active Ingredients
- FELIS CATUS HAIR
Indications and Usage
INDICATIONS AND USAGE Studies have shown that skin tests with cat extract are useful in the diagnosis of cat allergy. As a rule, persons with cat allergy have positive skin reactions when tested with cat extract, and non-allergic individuals rarely react (7, 8, 9). However, the relationship between a positive skin test and the appearance of clinical symptoms after exposure to a cat is not absolute, i.e., some skin-test positive persons do not experience allergic symptoms after exposure (10). Failure to experience symptoms may be dose related, since it is known that cats vary significantly in the amount of Fel d1 they produce (11). The efficacy of cat extract immunotherapy in the treatment of bronchial asthma has been shown in two studies (12, 13) A reduction in bronchial sensitivity was observed in five patients with cat allergy, whereas no reduction was observed in placebo treated, cat-allergic patients.
Warnings
WARNINGS Standardized Cat Hair Extract may cause local or severe life-threatening reactions when administered to highly sensitive individuals. Physicians who use this product should be familiar with the clinical use of allergenic extract and have the necessary emergency equipment and medications available to treat systematic allergic reactions See Precautions, Adverse Reactions and Overdosage . Standardized Cat Hair Extract should not be used interchangeably with Standardized Cat Pelt Extracts or previously standardized cat extracts labeled in Allergy Units per mL. Cat hair extracts labeled in BAU/mL made by other manufacturers should be tested for bioequivalency by serial titration skin testing before these products are used in patients who have previously received Allermed Standardized Cat Hair Extract. The dosage of Standardized Cat Hair Extract must be reduced when starting a patient on a new lot of Standardized Cat Hair Extract containing the same amount of Fel d1 units per mL. This is necessary due to a possible loss of potency during storage in the physician's office. The dose of the new lot of extract should not exceed 1/4 the last dose given from the old lot of extract. Any evidence of a strong local reaction or systemic reaction following the administration of Standardized Cat Hair Extract requires a reduction in dosage during the initial stages of immunotherapy, as well as during maintenance therapy.